KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $985.6 million.

  • Resmed's Receivables - Net rose 1461.7% to $985.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $985.6 million, marking a year-over-year increase of 1461.7%. This contributed to the annual value of $939.5 million for FY2025, which is 1220.83% up from last year.
  • Resmed's Receivables - Net amounted to $985.6 million in Q4 2025, which was up 1461.7% from $907.3 million recorded in Q3 2025.
  • Over the past 5 years, Resmed's Receivables - Net peaked at $985.6 million during Q4 2025, and registered a low of $508.6 million during Q1 2022.
  • Its 5-year average for Receivables - Net is $723.0 million, with a median of $698.6 million in 2023.
  • Its Receivables - Net has fluctuated over the past 5 years, first plummeted by 624.17% in 2022, then surged by 3493.73% in 2023.
  • Over the past 5 years, Resmed's Receivables - Net (Quarter) stood at $526.0 million in 2021, then increased by 27.8% to $672.3 million in 2022, then increased by 8.55% to $729.7 million in 2023, then rose by 17.84% to $859.9 million in 2024, then increased by 14.62% to $985.6 million in 2025.
  • Its last three reported values are $985.6 million in Q4 2025, $907.3 million for Q3 2025, and $939.5 million during Q2 2025.